Clincosm LogoSign in Get a demo

Prostate Adenocarcinoma

Showing 26 - 50 of 187
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma Trial in Rochester (Ulrasound Vibroelastography (UVE))

Suspended
  • Prostate Adenocarcinoma
  • Ulrasound Vibroelastography (UVE)
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Prostate Adenocarcinoma, Prostate Cancer, Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Boston (Apalutamide

Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Apalutamide [Erleada], darolutamide [Nubeqa], or enzalutamide [Xtandi]
  • Prostate-Specific Membrane Antigen (PSMA) PET/CT Scan
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jan 4, 2023

Prostate Cancer, Prostate Adenocarcinoma Trial in Charlotte (ADT+Docetaxel+Enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 12, 2023

Prostate Cancer, Prostate Cancer Metastatic, Prostate Adenocarcinoma Trial (Relugolix Pill, Ritonavir, Itraconazole)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Relugolix Pill
  • +2 more
  • (no location specified)
Dec 23, 2022

Localized Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Best Practice, Dietary Intervention, Exercise

Recruiting
  • Localized Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Best Practice
  • +4 more
  • Seattle, Washington
  • +1 more
Jan 9, 2023

Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • MRI-guided Intensity-Modulated Radiation Therapy
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 4, 2023

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester

Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Androgen Suppression
  • +3 more
  • Scottsdale, Arizona
  • +1 more
Jan 5, 2023

Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester

Active, not recruiting
  • Metastatic Prostate Adenocarcinoma
  • +6 more
  • Intensity-Modulated Radiation Therapy
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 5, 2023

Prostate Adenocarcinoma Trial in Kansas City (Osanetant)

Recruiting
  • Prostate Adenocarcinoma
  • Kansas City, Kansas
    The University of Kansas Cancer Center, Westwood Campus
Jan 3, 2023

Prostate Adenocarcinoma Trial in Kansas City (Osanetant)

Recruiting
  • Prostate Adenocarcinoma
  • Kansas City, Kansas
    The University of Kansas Cancer Center, Westwood Campus
Jan 3, 2023

Prostate Adenocarcinoma, Localized Prostate Carcinoma Trial in San Francisco (High Dose Rate Monotherapy)

Not yet recruiting
  • Prostate Adenocarcinoma
  • Localized Prostate Carcinoma
  • High Dose Rate Monotherapy
  • San Francisco, California
    University of California, San Francisco
Dec 27, 2022

Work Experience in Patients With Stage I-III Prostate Cancer

Recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Interview
  • Questionnaire Administration
  • Phoenix, Arizona
  • +324 more
Dec 21, 2022

Prostate Cancer, Prostate Adenocarcinoma Trial in Tampa (Sunphenon, Placebo)

Recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Tampa, Florida
  • +1 more
Dec 19, 2022

Prostate Adenocarcinoma Trial in Columbus (Dietary Intervention, Questionnaire Administration)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Dietary Intervention
  • Questionnaire Administration
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 9, 2022

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)

Active, not recruiting
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Abiraterone Acetate
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8

Recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Discussion
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Dec 1, 2022

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial

Active, not recruiting
Has Results
  • Hormone-Resistant Prostate Cancer
  • +6 more
  • Pembrolizumab
  • pTVG-HP Plasmid DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 8, 2022

Male Erectile Disorder, Prostate Adenocarcinoma, Erectile Dysfunction, CTCAE Trial in Houston (Atorvastatin, Pentoxifylline,

Completed
  • Male Erectile Disorder
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 21, 2022

Prostate Adenocarcinoma, PSA Level Greater Than Ten, Stage IIB Prostate Cancer AJCC v8 Trial in Houston (Hyperpolarized Carbon C

Active, not recruiting
  • Prostate Adenocarcinoma
  • +9 more
  • Hyperpolarized Carbon C 13 Pyruvate
  • Magnetic Resonance Spectroscopic Imaging
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Quantitative HP MRI for Clinical Prostate Cancer Exam

Active, not recruiting
  • Prostate Adenocarcinoma
  • Hyperpolarized Carbon C 13 Pyruvate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Castration-Resistant Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Prostate Adenocarcinoma Trial in Houston

Completed
Has Results
  • Castration-Resistant Prostate Carcinoma
  • +5 more
  • Durvalumab
  • Tremelimumab
  • Houston, Texas
    M D Anderson Cancer Center
Nov 9, 2022

Prostate Adenocarcinoma, Prostate Cancer Trial (Transvesical Single Port Robotic Partial Prostatectomy, High-intensity focused

Not yet recruiting
  • Prostate Adenocarcinoma
  • Prostate Cancer
  • Transvesical Single Port Robotic Partial Prostatectomy
  • High-intensity focused ultrasound (HIFU)
  • (no location specified)
Nov 3, 2022

Prostate Adenocarcinoma Trial in Valence, Clermont-Ferrand, Lyon (Integrated boost)

Recruiting
  • Prostate Adenocarcinoma
  • Integrated boost
  • Valence, Drôme, France
  • +3 more
Oct 26, 2022

Prostate Cancer, Cancer of Prostate, Prostate Adenocarcinoma Trial (Stereotactic Ablative Body Radiation)

Not yet recruiting
  • Prostate Cancer
  • +2 more
  • Stereotactic Ablative Body Radiation
  • (no location specified)
Oct 26, 2022

Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Montreal (131I-PSMA-1095 Radioligand Therapy (RLT))

Active, not recruiting
  • Prostate Cancer
  • +5 more
  • 131I-PSMA-1095 Radioligand Therapy (RLT)
  • Montreal, Quebec, Canada
    Stephan Probst
Oct 24, 2022